Cello Health 'making good headway' with decent organic growth - Mark Scott, chief executive of Cello Health plc 00:00:00
Mark Scott, chief executive of Cello Health plc (LON:CLL) tells Proactive Investors they enjoyed a good rise in half-year profits, driven by another six months of strong growth from its Cello Health division.